Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurent Deferred Tax LiabilityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Short term Debt (2016 - 2020)

Historic Short term Debt for Amdocs (DOX) over the last 9 years, with Q3 2020 value amounting to $100.0 million.

  • Amdocs' Short term Debt changed N/A to $100.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $100.0 million, marking a year-over-year change of. This contributed to the annual value of $100.0 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q3 2020, Amdocs' Short term Debt is $100.0 million.
  • Amdocs' Short term Debt's 5-year high stood at $200.0 million during Q3 2016, with a 5-year trough of $50.0 million in Q1 2020.
  • In the last 3 years, Amdocs' Short term Debt had a median value of $150.0 million in 2016 and averaged $137.5 million.
  • The largest annual percentage gain for Amdocs' Short term Debt in the last 5 years was 909.09% (2016), contrasted with its biggest fall of 909.09% (2016).
  • Quarter analysis of 3 years shows Amdocs' Short term Debt stood at $200.0 million in 2016, then changed by 0.0% to $200.0 million in 2017, then tumbled by 50.0% to $100.0 million in 2020.
  • Its Short term Debt was $100.0 million in Q3 2020, compared to $50.0 million in Q1 2020 and $200.0 million in Q1 2017.